Nuvvagen Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Nuvvagen Bioscience
Nuvvagen Bioscience Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2019 (Five years and four months 27 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vasant Sangani and Dhavall Sangani serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24234MH2019PTC330749
-
Company No.
330749
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nuvvagen Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhavall Sangani
|
Director | 19-Sep-2019 | Current |
|
Vasant Sangani
|
Director | 19-Sep-2019 | Current |
Financial Performance of Nuvvagen Bioscience.
Nuvvagen Bioscience Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuvvagen Bioscience?
Unlock access to Nuvvagen Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
_PRIVATE_LIMITED.webp)
Vrinda Chemicals (India) Private LimitedVasant Sangani is a mutual person
-
Vajrachem India LimitedVasant Sangani and Dhavall Sangani are mutual person
-
Vajra Reaalty LlpVasant Sangani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nuvvagen Bioscience?
Nuvvagen Bioscience has a workforce of 16 employees as of Dec 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuvvagen Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvvagen Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.